Vinaora Nivo Slider

The Cardno ChemRisk View

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Bloggers
    Bloggers Search for your favorite blogger from this site.
  • Archives
    Archives Contains a list of blog posts that were created previously.
  • Login
    Login Login form
Posted by on in Centers of Excellence
  • Font size: Larger Smaller
  • Hits: 1364

Cardno ChemRisk Publishes Meta-Analysis on Gender-Specific Risks of Hip Implant Revisions

Recently, our study “An assessment of gender-specific risk of implant revision following primary total hip arthroplasty: a systematic review and meta-analysis” was published in the Journal of Arthroplasty (Towle and Monnot 2016). Scientists at Cardno ChemRisk synthesized and examined the evidence on the relative risk of revision in men and women following primary total hip arthroplasty (THA). THA surgeries involve the replacement of damaged hip joints with prosthetic components in an effort to mitigate hip pain. Over time, some THA surgeries require revision due to various modes of failure, such as dislocation, infection, or aseptic loosening. A better understanding of factors that influence the risk of revision due to hip implant failure would help reduce post-surgery complications. Therefore, we performed a meta-analysis to examine if males or females are at a higher risk of revision.

Overall, findings suggested that males are at an increased risk of revision following THA when compared to females. Additionally, this study provided evidence that gender-specific risk of revision may be impacted by geographic location (i.e. United States and Europe) and time period of THA operation (i.e. post-2000). The authors discussed potential risk factors for revision among male hip implant patients, including differences in hip anatomy, degree of surgical trauma during surgery, level of physical activity following surgery, as well as differences in primary care provider interactions.

The abstract of the article is available here.  If you have any questions regarding the paper, please contact Kevin Towle or Andrew Monnot.
Rate this blog entry:
0
Ms. Melanie Nembhard is an Associate Health Scientist with Cardno ChemRisk in the San Francisco, CA office. She earned her MSPH in Occupational and Environmental Hygiene from the Johns Hopkins Bloomberg School of Public Health. She also holds two certificates from Johns Hopkins, the Risk Sciences and Public Policy Certificate and the Population and Health Certificate. Ms. Nembhard’s principal areas of training and expertise include industrial hygiene and risk assessment. Since joining Cardno ChemRisk, she has provided litigation support for cases related to asbestos, benzene, butadiene, diacetyl, worker safety, welding, sunscreen, dermal exposures to various chemicals, and inhalation irritants. Additionally, she has participated in baseline exposure assessments at multiple oil refineries regarding occupational and environmental exposures to various chemical and physical agents, including particulates, volatile organic compounds, and noise.

The Cardno ChemRisk View

We're glad you decided to check us out.

Cardno ChemRisk is a respected scientific consulting firm headquartered in San Francisco with locations and consultants across the U.S. While our website provides a formal look at our capabilities, the Cardno ChemRisk View provides an informal voice too. Various Cardno ChemRisk consultants will be sharing news and views about current trends, happenings and methodologies in the industry. We’ll also highlight activities of interest at Cardno ChemRisk, within confidentiality restrictions of course.

The intent is to keep you informed and enable productive conversations, so please join in and get to know our staff and what makes our people unique. We are enthusiastic about the blogging experience and hope you will return often to learn and share. Stay tuned by subscribing to our blog or clicking on the RSS feed.

 

 

 

 

Cardno ChemRisk View Subscribers